Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
Rollie C, Chevallereau A, Watson BNJ, Chyou TY, Fradet O, McLeod I, Fineran PC, Brown CM, Gandon S, Westra ER.
Rollie C, et al. Among authors: brown cm.
Nature. 2020 Feb;578(7793):149-153. doi: 10.1038/s41586-020-1936-2. Epub 2020 Jan 22.
Nature. 2020.
PMID: 31969710
Free PMC article.